NEW MODALITIES FOR TREATMENT OF DRUG-RESISTANT TUBERCULOSIS AND OTHER DISEASES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100204310A1
SERIAL NO

12556933

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

selected from protein 30, 32A and 32B, and further having 5′ and 3′ palindromic hairpin-forming sequences, said compound being covalently linked to a protein synthesis inhibiting antibiotic via a linker. The invention further provides pharmaceutical formulations of such compounds and methods of use thereof for treating tuberculosis. Other diseases may similarly be treated by tethering and antibiotic which targets a ribosomal protein to an antisense oligonucleotide complementary to an mRNA involved in the disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ZATA PHARMACEUTICALS INC60 PRESCOTT STREET WORCESTER MA 01605

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Pierson, Karen Cambridge, US 1 0
Tabatadze, David Worcester, US 10 478
Zamecnik, Paul C Boston, US 24 1778

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation